HEDGES ASSET MANAGEMENT LLC CRISPR Therapeutics AG Transaction History

HEDGES ASSET MANAGEMENT LLC portfolio value:

$685,000
portfolio value

HEDGES ASSET MANAGEMENT LLC quarter portfolio value change:

+7.54%
quarter

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -15.35% -1.9K shares -68K $65.35 10.47K
Q2 2022 share Increase +26.60% 2.6K shares 139K $60.77 12.37K
Q1 2022 share Increase +17.07% 1.42K shares -19K $62.77 9.77K
Q4 2021 share Increase 0.00% 8.35K shares 633K $78.85 8.35K